Analyst firms · BofA Securities · ELV

BofA Securities ELV price target and rating history

Elevance Health Inc. (ELV) · Health Care

BofA Securities rates Elevance Health Inc. (ELV) Buy with a $435 price target, as of its latest action on Apr 29, 2026. It has published 3 rating actions on ELV since September 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a ELV price target in the last 12 months, the median target is $425. BofA Securities's $435 is 2% above that.

Current rating
Buy
Price target
$435
Median target, all firms
$425
Actions on ELV
3

BofA Securities price target on ELV

$575$505$4352023202420252026
BofA Securities price target on ELV, each point a stated target, September 2022 to April 2026.

Every BofA Securities rating on ELV

How other firms rate ELV

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Deutsche BankBuy$498May 20, 2026
BofA SecuritiesBuy$435Apr 29, 2026
Evercore ISIIn-line$345Apr 8, 2026
RBC Capital MarketsSector Perform$358Feb 3, 2026
Wolfe ResearchOutperform$425Jan 8, 2026

Questions about BofA Securities and ELV

What is BofA Securities's price target for ELV?
BofA Securities's latest stated price target for Elevance Health Inc. (ELV) is $435, from its action on Apr 29, 2026.
What is BofA Securities's rating on ELV?
BofA Securities rates ELV Buy, a bullish rating, as of Apr 29, 2026.
When did BofA Securities last change its view on ELV?
On Apr 29, 2026, BofA Securities upgrades to Buy from Neutral, price target $435.
How does BofA Securities's ELV target compare with other analysts?
Across 5 firms with a ELV price target in the last 12 months, the median target is $425. BofA Securities's $435 is 2% above that.

More ELV rating histories

All BofA Securities ratingsELV news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.